HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Regulation/Legislation (Cosmetics)

Regulation

Set Alert for Regulation (Beauty)

Latest From Beauty & Regulation

Sunscreen Ecological Risk Assessment 'Teed Up' For US EPA

Lawmakers in Hawaii and other jurisdictions may be left wanting by the National Academies of Sciences' sunscreen report, but industry groups were pleased with the academy's findings and recommendations to the EPA. The Personal Care Products Council says it confirms that scientific data are insufficient at present to conduct “realistic” ecological risk assessments of UV filters or support their bans.

Ingredients FDA

Senate Proposes Smaller Boost Than House For FDA FY2023 Appropriation

Senate Appropriations Committee proposes $1.185bn to CFSAN and $2.19bn to CDER, both levels short of House appropriators passed in June. FDA requested $30.36m in user fees from monograph drugs but no amount was specified in Senate draft bill.

FDA Legislation

US FDA Seeks Benzene Testing Of 200 Drug Products By Contract Lab

The agency is calling for an ISO 17025-accredited or equivalent partner to screen selected drug products for benzene, following a rash of sunscreen, antiperspirant and other OTC drug product recalls which triggered a rush on testing laboratories, as well as class action filings across the US.

FDA Quality

PCPC Pushes FDA For Bigger Industry Role In Developing Quality Metrics Reporting For Drugs

Especially if the program eventually will be made mandatory, the US FDA must engage more with drug industry representatives – including OTC – as its plan for quality metric reporting continues taking shape, the trade association says.

FDA OTC Drugs

US FDA User Fees: Lay-Off Notices Planned For Early September If Congress Doesn’t Pass Bill

The notices normally would go out on 1 August, but unspent user fee funds may be able to sustain work for a few weeks if the program expires.

FDA User Fees

Family Dollar Recalls 435 Consumer Health, Personal Care Products Due To Storage Temps

Firms says products recalled were “inadvertently shipped to certain stores” after “being stored outside of labeled temperature requirements." Recalls include oral products and nasal sprays, oral care products, sunscreen and other topicals, supplements and variety of personal care SKUs.

OTC Drugs Retail
See All

Legislation

Set Alert for Legislation (Beauty)

Latest From Beauty & Legislation

Senate Proposes Smaller Boost Than House For FDA FY2023 Appropriation

Senate Appropriations Committee proposes $1.185bn to CFSAN and $2.19bn to CDER, both levels short of House appropriators passed in June. FDA requested $30.36m in user fees from monograph drugs but no amount was specified in Senate draft bill.

FDA Legislation

US FDA User Fees: Lay-Off Notices Planned For Early September If Congress Doesn’t Pass Bill

The notices normally would go out on 1 August, but unspent user fee funds may be able to sustain work for a few weeks if the program expires.

FDA User Fees

Hawaii’s Big Island Joins Maui In Non-Mineral Sunscreen Ban

A National Academies of Sciences report is expected in coming weeks on the environmental impacts of sunscreen ingredients and potential human health issues associated with changing use patterns. But Hawaii County legislators decided they couldn’t wait for new information to come to light, voting yes on a measure to ban sales of non-mineral sunscreens, which became law on 8 July.

US States Legislation

IFRA Upholds 50 Years Of Risk Assessment, Scent ‘Essentiality’ In Green Deal Policy Recommendations

Essentiality criteria for substances categorized as “most harmful” in the EU – which otherwise may be banned under the Chemicals Strategy for Sustainability – must take into account social and societal benefits, says the International Fragrance Association in recently published Green Deal policy recommendations.

Europe Sustainability

‘Skinny’ US FDA User-Fee Reauthorization Would Omit Cosmetics, Supplement Regulation Reforms

Cosmetics and dietary supplement program reforms may have to wait if Republican Sen. Burr's stripped-down version of US FDA user-fee reauthorization package – which tracks with companion legislation already passed in the House – is the best Congress can do before the August recess.

Legislation Cosmetics

California Will Lead US With Bold Plastic Waste Law Targeting Product Packaging

Governor Gavin Newsom on 30 June signed into law the Plastics Pollution Prevention and Packaging Responsibility Act, which sets thresholds and timelines for reducing plastic use and meeting recycling goals, shifting recycling burden from consumers to producers.

Legislation Packaging
See All

Litigation

Set Alert for Litigation (Beauty)

Latest From Beauty & Legal Issues

Revlon Gains $1.4Bn Financing From Subsidiaries, Appoints Interim CFO Amid Bankruptcy Fallout

Revlon approved for $1.4bn debtor-in-possession financing from BrandCo Lenders, a group of operating subsidiaries formed in capital structure changes which owns much of Revlon’s intellectual property. Firm appoints interim CFO to set course for debt restructuring.

Cosmetics Legal Issues

J&J Pulls Plug On Talc Across Its Baby Powder Portfolio, Shifts To Cornstarch-Based Products

As it did when it halted sales in US and Canada in 2020, J&J’s latest announcement attributes its decision as coming from a “portfolio assessment” and stated it remains confident in using talc in baby powder and cosmetics.

Business Strategies Cosmetics

Benzene Suits Against US Personal-Care Firms Appear Headed In One Direction: Settlement

The latest in litigation against Unilever, P&G, Beiersdorf and J&J alleging violations for selling personal-care products contaminated with benzene.

Legal Issues Quality

Coppertone Facial Sunscreen Is Repackaged Body Lotion At Higher Price – Proposed Class Action

Beiersdorf, Inc. labels its Coppertone Sport Mineral FACE sunscreen as formulated for face. Aside from its higher cost and different bottle, however, it is no different from Coppertone Sport Mineral lotion, claims a lawsuit filed in Connecticut federal court seeking class action status. 

Legal Issues Advertising, Marketing & Sales

PCPC Weighs In On Hand Sanitizer ‘Kills 99.99% Of Germs’ Appeal Pending In Ninth Circuit

Do reasonable consumers expect that a hand sanitizer advertised as lethal to 99.99% of germs will protect them against 99.99% of pathogens on the planet? Can a federal court address that point at the pleadings stage? Such questions will fall to the US Court of Appeals for the Ninth Circuit following dismissal of a putative class action against Vi-Jon in 2021 by California’s Southern District.

United States Legal Issues

EU's Highest Court Advised Prostaglandin Eyelash Serum Is Not A Medicine Per Se

Just because the use of a substance in a cosmetic product, in this case prostaglandin-derivative methylamide-dihydro-noralfaprostal, has a physiological effect does not mean it's a medicinal product by function, advises the Advocate General of the Court of Justice of the EU in a recent opinion. While the opinion does not bind the CJEU to any decision, it may impact discussions elsewhere with regards to these substances, for example in the US.

Europe Beauty
See All
UsernamePublicRestriction

Register